Delivery Order SPE2DB24D1007-SPE2DB25FCCPT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin, with a ceiling value of $3,456.73. This competitively awarded, firm fixed-price delivery order was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. No set-aside designation was used for...
- The Defense Logistics Agency awarded a delivery order valued at $8,824.05 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The contract, which was competitively awarded with no set-aside designation, was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. AmerisourceBergen Drug Corp will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, leveraging its established position as a...
- This delivery order, awarded July 25, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 1 million units of Lantus SoloStar 100 Unit/ML 3ML insulin at a ceiling value of $1,429.34. The order, which is non-set-aside and competitively awarded, is scheduled for completion by July 28, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $3,049.07 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This firm fixed price contract, with an ultimate completion date of July 24, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was competitively awarded with no set-aside designation, with performance to be executed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL 3mL insulin, a diabetes management medication, with a contract ceiling value of $2,796.98. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, under a firm fixed price delivery order structure. This is a non-set-aside, competitively awarded contract, and performance will be executed at the vendor's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,022.80 firm fixed-price contract is for the supply of Lantus SoloStar 100 unit/mL 3mL, a type of insulin medication. The contract has an ultimate completion date of March 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This is a $8,455.38 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- The Defense Logistics Agency awarded a $1,301.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/ML 3ML insulin, with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a direct delivery of pharmaceutical products to support federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- The Defense Logistics Agency awarded a $7,444.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar insulin (100 units/mL, 3mL formulation) with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor, reflecting DLA's ongoing procurement of critical medical supplies for military and federal healthcare systems. The delivery order is issued under...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCPTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lantus SoloStar 100 unit/mL insulin in 3 mL formulations, with a ceiling value of $2,014.04. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement needs across multiple therapeutic domains through competitively awarded contracts with the DLA and Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 7/24/25 |